Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S R Frankel

Leukemia

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Leukemia|January 1, 1994
Treatment of acute promyelocytic leukemia with all-trans retinoic acid: an update of the New York experienceR P Warrell, P Maslak, A Eardley, et al.
Leukemia|June 1, 1994
Treatment of acute promyelocytic leukemia with all-trans retinoic acid: an update of the New York experienceR P Warrell, P Maslak, A Eardley, et al.
Leukemia|April 16, 2004
G3139, a Bcl-2 antisense oligodeoxynucleotide, induces clinical responses in VAD refractory myelomaN W C J van de Donk, O de Weerdt, G Veth, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Leukemia|January 1, 1994
Treatment of acute promyelocytic leukemia with all-trans retinoic acid: an update of the New York experienceR P Warrell, P Maslak, A Eardley, et al.
Leukemia|June 1, 1994
Treatment of acute promyelocytic leukemia with all-trans retinoic acid: an update of the New York experienceR P Warrell, P Maslak, A Eardley, et al.
Leukemia|April 16, 2004
G3139, a Bcl-2 antisense oligodeoxynucleotide, induces clinical responses in VAD refractory myelomaN W C J van de Donk, O de Weerdt, G Veth, et al.
Pageof 1